University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

Venetoclax Can Effectively Target AML Stem Cells Through Acid-Fueled OXPHOS, AML M5 Is a Risk Factor for Lack of Response to Venetoclax

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Daniel Pollyea
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Daniel Pollyea
0 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
AML Biology and Treatment
20:35
University of Miami's 2nd Biennial Miami Leukemia Symposium

Curing APL in 2020: Have We Completely Deciphered Mechanism(s) of Co…

Feat. M. Tallman
16:42
University of Miami's 2nd Biennial Miami Leukemia Symposium

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of R…

Feat. E. Stein
20:28
University of Miami's 2nd Biennial Miami Leukemia Symposium

Tailoring Therapies to Target Leukemia Stem Cells: PU-FITC Binding A…

Feat. M. Guzman
23:05
University of Miami's 2nd Biennial Miami Leukemia Symposium

Venetoclax Can Effectively Target AML Stem Cells Through Acid-Fueled…

Feat. D. Pollyea